When a surgeon performs a minimally invasive hysterectomy for endometrial cancer, they often use a tool called an intrauterine manipulator to help position the uterus. A new analysis of over 10,000 patient records suggests that using this tool might be linked to a slightly higher chance of the cancer returning. The study found that patients who had the manipulator used had an 18% higher risk of their disease coming back, compared to those who didn't. The analysis didn't find a clear, significant link to worse overall survival, though the numbers trended in that direction.
It's crucial to understand what this study is—and isn't. This is a meta-analysis, which means researchers pooled data from 12 existing studies, most of which were retrospective. That means they looked back at medical records, not forward in a controlled trial. Because of this design, the evidence is considered low to moderate quality. The researchers themselves note that most of the studies didn't fully account for other factors that affect cancer outcomes, like the specific type of tumor or whether patients received additional treatment after surgery. Several studies also had a moderate to serious risk of bias in how they were conducted.
This analysis shows an association, not proof of cause and effect. It doesn't mean the tool causes cancer to spread. What it does do is highlight a potential safety signal that deserves a closer, more rigorous look. The findings warrant investigation in future, carefully designed prospective trials where all other factors can be better controlled. For now, it's a piece of evidence for surgeons and patients to be aware of when discussing surgical options.